[1]覃 璧,韦霁芸,石德敏,等.不同促排卵方案在子宫内膜异位症合并不孕患者体外受精治疗中的效果比较[J].医学信息,2022,35(08):118-120.[doi:10.3969/j.issn.1006-1959.2022.08.029]
　QIN Bi,WEI Ji-yun,SHI De-min,et al.Comparison of the Effects of Different Ovulation Induction Regimens on In Vitro Fertilization in Patients with Endometriosis Complicated with Infertility[J].Medical Information,2022,35(08):118-120.[doi:10.3969/j.issn.1006-1959.2022.08.029]
点击复制

不同促排卵方案在子宫内膜异位症合并不孕患者体外受精治疗中的效果比较()
分享到：

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
35卷
期数:
2022年08期
页码:
118-120
栏目:
临床研究
出版日期:
2022-04-15

文章信息/Info

Title:
Comparison of the Effects of Different Ovulation Induction Regimens on In Vitro Fertilization in Patients with Endometriosis Complicated with Infertility
文章编号:
1006-1959（2022）08-0118-03
作者:
覃 璧; 韦霁芸; 石德敏; 等
（河池市人民医院生殖中心，广西 河池 547000）
Author(s):
QIN Bi; WEI Ji-yun; SHI De-min; et al.
(Reproductive Center of Hechi People’s Hospital,Hechi 547000,Guangxi,China)
关键词:
促排卵方案; 拮抗剂方案; 子宫内膜异位症; 不孕; 体外受精
Keywords:
Ovulation promotion program; Antagonist programme; Endometriosis; Infertility; In vitro fertilization
分类号:
R711.71
DOI:
10.3969/j.issn.1006-1959.2022.08.029
文献标志码:
A
摘要:
目的 研究不同促排卵方案在子宫内膜异位症合并不孕患者体外受精治疗中的效果。方法 选取2017年6月-2021年5月在我院接受体外受精治疗的子宫内膜异位症伴不孕患者112例，采用随机数字表法分为观察组和对照组，每组56例。观察组予以拮抗剂促排卵方案，对照组予以超长促排卵方案,比较两组临床指标（GnRH-a使用总量、获卵数量、注射hCG时子宫内膜厚度、优胚数量、胚胎移植数量、胚胎冷冻数量）与临床结局（种植、妊娠、流产、异位妊娠）。结果 观察组体外受精治疗中GnRH-a使用总量、获卵数量少于对照组，注射hCG时子宫内膜厚度低于对照组（P＜0.05）；而两组优胚数量、胚胎移植数量与胚胎冷冻数量、种植比例、妊娠比例、流产比例、异位妊娠比例比较，差异无统计学意义（P＞0.05）。结论 拮抗剂促排卵方案与超长促排卵方案在子宫内膜异位症合并不孕患者体外受精治疗中临床结局无明显差异，但拮抗剂促排卵方案GnRH-a使用总量更少，临床可结合患者实际情况合理选择不同促排卵方案。
Abstract:
Objective To study the effect of different ovulation induction regimens on in vitro fertilization in patients with endometriosis complicated with infertility.Methods A total of 112 patients with endometriosis and infertility who received in vitro fertilization in our hospital from June 2017 to May 2021 were divided into observation group and control group by random number table method, with 56 cases in each group. The observation group was given an antagonist ovulation promotion program, and the control group was given an ultra-long ovulation promotion program. The clinical indicators (total amount of GnRH-a used, number of eggs harvested, endometrial thickness when hCG injected, number of excellent embryos, retrieved oocyte number, number of embryos frozen) and clinical outcomes (implantation, pregnancy, abortion, ectopic pregnancy) were compared between the two groups.Results The total amount of GnRH-a and retrieved oocyte number in the observation group were less than those in the control group, and the endometrial thickness at hCG injection was lower than that in the control group (P<0.05). There was no significant difference between the two groups in the number of excellent embryos, the number of embryos transferred and the number of frozen embryos, implantation rate, pregnancy rate, abortion rate and ectopic pregnancy rate (P>0.05).Conclusion There is no significant difference in the clinical outcome between the antagonist ovulation promotion program and the ultra-long ovulation promotion program in the in vitro fertilization treatment of patients with endometriosis and infertility. However, the total amount of GnRH-a used in the antagonist ovulation induction protocol is less. Different ovulation induction protocols can be reasonably selected according to the actual situation of patients.

参考文献/References:

[1]赵璇,任志红.子宫内膜异位症合并不孕症的发病原因及不同方法的治疗效果分析[J].中国妇幼保健,2019,34(4):872-874.[2]陈曼,林虹,王玉莲,等.子宫内膜异位症相关不孕患者体外受精/卵胞浆内单精子注射助孕方案的比较[J].实用医学杂志,2020,36(17):100-104.[3]何丽清,蔡序子,王艳,等.子宫内膜异位症腹腔镜保守治疗术后联用GnRHa对临床妊娠率的影响[J].南方医科大学学报,2018,38(5):98-102.[4]中华医学会妇产科学分会子宫内膜异位症协作组.子宫内膜异位症的诊治指南[J].中华妇产科杂志,2015,50(5):161-169.[5]鲍玉敏,曾湘晖,王莉云.子宫内膜异位症不同分期妇女行辅助生殖助孕的结局分析[J].贵州医药,2019,43(8):97-99.[6]马黔红,黄仲英.辅助生殖技术中胚胎冻存新观念及解冻移植策略的探讨[J].实用妇产科杂志,2020,36(4):8-10.[7]吴亚男,李红霞,霍志平,等.不同R-AFS分期子宫内膜异位症患者血清CA125及BDNF检测及其诊断价值[J].临床和实验医学杂志,2019,18(10):73-75.[8]赵华,王雪,耿嘉瑄,等.人类胚胎线粒体三磷酸腺苷和钙离子水平与胚胎形态学分型的关系研究[J].中华实用诊断与治疗杂志,2018,32(6):533-535.[9]孙艳,王文祥,陈文翰,等.基于生物信息学分析子宫内膜异位症与不孕症在基因组学与蛋白组学层面的关联[J].生殖医学杂志,2020,29(12):109-114.[10]李金姑,石淑卿,林元.C-myc和cyclin D1在子宫内膜异位症中免疫反应性增强[J].中国组织化学与细胞化学杂志,2017,26(2):152-159.[11]王玲娟,魏薇.腹腔镜卵巢子宫内膜异位囊肿剥除术对卵巢储备功能的影响[J].中国生育健康杂志,2018,29(1):86-88.[12]郭莹,蒋向荣,杨娜,等.生长激素联合不同促排卵方案对卵巢储备功能减退高龄女性IVF-ET结局的影响[J].中国优生与遗传杂志,2018,26(6):132-134.[13]梁婷,黄伟媚.卵泡期高孕酮状态下促排卵方案与长方案促排卵在高龄卵巢功能低下患者中的应用效果比较[J].广西医学,2019,41(9):1082-1085.[14]黄伟媚,黄卡立.子宫腺肌病合并不孕接受达菲林超长方案超促排卵后行IVF-ET治疗效果回顾性分析[J].中国性科学,2018,27(7):82-85.[15]田雪子,赵飞燕,王树玉,等.不同促排卵方案对卵巢子宫内膜异位囊肿术后卵巢储备功能下降患者IVF-ET助孕结局的影响[J].中国优生与遗传杂志,2019,16(3):355-356.[16]温灿鑫,潘萍,刘庆洲,等.GnRH激动剂延长降调节方案改善有症状的子宫瘢痕憩室患者体外受精助孕结局[J].生殖医学杂志,2020,29(5):586-592.[17]焦旭梅,高小琴.不同促排卵方案对子宫内膜异位症患者卵泡液中血管内皮生长因子水平及其助孕结局的影响[J].中国药物与临床,2020,20(15):2569-2571.[18]廖旖欣,全松.卵巢储备功能的评估与控制性卵巢刺激方案的选择[J].实用妇产科杂志,2019,35(5):324-326.

相似文献/References:

[1]许菲菲,顾益惠,夏 飞.抑制素B在拮抗剂方案体外受精-胚胎移植中的变化及价值[J].医学信息,2022,35(07):79.[doi:10.3969/j.issn.1006-1959.2022.07.019]
　XU Fei-fei,GU Yi-hui,XIA Fei.Changes and Value of Inhibin B in Antagonist Protocol In Vitro Fertilization-embryo Transfer[J].Medical Information,2022,35(08):79.[doi:10.3969/j.issn.1006-1959.2022.07.019]

更新日期/Last Update: 1900-01-01